Drug class
Zidovudine
Zidovudine is a specific antiretroviral active pharmaceutical ingredient rather than an independent therapeutic drug class; it belongs to the nucleoside reverse transcriptase inhibitor class. Read more about Zidovudine
14 drugs in this class 9 manufacturers
Drugs in Zidovudine
ZIDOVUDINE
ZIDOVUDINE
RETROVIR (zidovudine)
ZIDOVUDINE
ZIDOVUDINE
LAMIVUDINE-ZIDOVUDINE (lamivudine/zidovudine)
ZIDOVUDINE
ZIDOVUDINE
Zidovudine is a specific antiretroviral active pharmaceutical ingredient rather than an independent therapeutic drug class; it belongs to the nucleoside reverse transcriptase inhibitor class.
Functioning as a synthetic thymidine analog, the drug undergoes intracellular phosphorylation to compete with endogenous nucleotides, incorporating into viral DNA and terminating chain elongation by inhibiting the human immunodeficiency virus reverse transcriptase enzyme.
Clinically, it is utilized as part of combination antiretroviral regimens for the management of HIV-1 infection and as prophylaxis to prevent perinatal transmission from parent to infant.
-
medlineplus.gov
Zidovudine is a specific antiretroviral active pharmaceutical ingredient rather than an independent therapeutic drug class; it belongs to the nucleoside reverse transcriptase inhibitor class
-
nih.gov
Zidovudine is a specific antiretroviral active pharmaceutical ingredient rather than an independent therapeutic drug class; it belongs to the nucleoside reverse transcriptase inhibitor class Clinically, it is utilized as part of combination antiretroviral regimens for the management of HIV-1 infection and as prophylaxis to prevent perinatal transmission from parent to infant
-
nih.gov
Functioning as a synthetic thymidine analog, the drug undergoes intracellular phosphorylation to compete with endogenous nucleotides, incorporating into viral DNA and terminating chain elongation by inhibiting the human immunodeficiency virus reverse transcriptase enzyme
-
nih.gov
Functioning as a synthetic thymidine analog, the drug undergoes intracellular phosphorylation to compete with endogenous nucleotides, incorporating into viral DNA and terminating chain elongation by inhibiting the human immunodeficiency virus reverse transcriptase enzyme Clinically, it is utilized as part of combination antiretroviral regimens for the management of HIV-1 infection and as prophylaxis to prevent perinatal transmission from parent to infant
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.